Public Calendar: May 24-30, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
Event Date: 05/28/2020
Location: Teleconference
Subject: Gates Foundation: Vaccine Development
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Several Gates Foundation staff
Event Date: 05/29/2020
Location: Teleconference
Subject: COVID-19 Vaccines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups affiliated with Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization (BIO)
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
Event Date: 05/28/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 05/29/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from the produce industry and trade associations
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 05/27/2020
Location: WebEx
Subject: COVID-19 Temporary Ingredient Labeling Guidance
FDA Participant/Group: DANIELLE SCHOR; LAURA CARROLL; CLAUDINE KAVANAUGH; KARI BARRETT; PATRICIA HANSEN;
Non FDA Participant/Group: Donna Garran, Jeannie Shaughnessy, Lee Sanders (Food and Beverage Issue Alliance (FBIA));
Event Date: 05/28/2020
Location: WebEx
Subject: COVID-19 Temporary Ingredient Labeling Guidance
FDA Participant/Group: LYNN SZYBIST; DANIELLE SCHOR; CLAUDINE KAVANAUGH; EMILY ROSE CAREY; STEFANO LUCCIOLI; JENNIFER DOOREN; LAURA CARROLL; PATRICIA HANSEN;
Non FDA Participant/Group: Jason Linde, Lisa Gable, Steve Danon (Food Allergy Research and Education (FARE));
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event